Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-13 · accession 0001568605-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-16 | 2025-12-15 | SANA | Wyrick Susan D. | See Remarks | F - Tax | $5.22 | -873 | 180.8K | -0.5% | -$4,557 |
| D | 2025-12-16 | 2025-12-13 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | +3,400 | 181.7K | +2% | $0 |
| D | 2025-12-16 | 2025-12-13 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | — | -3,400 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | F | D | 873 | $5.22 | 180,790 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-13 | M | A | 3,400 | $0.00 | 181,663 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-12-13 | M | D | 3,400 | — | 0 | D | — · — to — | 3,400 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock. (F2) The award vested as to 100% of the restricted stock units on December 13, 2025. |